Company Overview

TerrAscend Corp. is a North American cannabis company focused on the cultivation, processing, distribution, and retail sale of medical and adult-use cannabis products. The company operates primarily in the regulated cannabis industry across the United States and Canada, with activities spanning cultivation facilities, branded consumer packaged goods, wholesale distribution, and dispensary retail operations. TerrAscend trades publicly in the United States on the OTCQX market under the ticker TSNDF and in Canada on the Toronto Stock Exchange under the ticker TSND.

The company’s primary revenue drivers are cannabis retail sales, branded product sales, and wholesale distribution. Its operations are concentrated in limited-license U.S. cannabis markets, particularly Pennsylvania, New Jersey, Maryland, Michigan, and California. TerrAscend has developed a vertically integrated operating model in several jurisdictions, allowing it to control cultivation, manufacturing, and retail channels. The company evolved from a Canadian cannabis operator into a predominantly U.S.-focused multi-state operator (MSO) through acquisitions, licensing expansions, and strategic retail growth following cannabis legalization trends in key states.

Business Operations

TerrAscend organizes its business around vertically integrated cannabis operations that include cultivation, processing, manufacturing, wholesale distribution, and retail dispensaries. Its principal operating units include The Apothecarium retail dispensary brand, Gage Cannabis, and other proprietary cannabis product brands sold through both company-owned and third-party retail channels. Revenue is generated primarily through direct-to-consumer dispensary sales and wholesale distribution of flower, concentrates, vapes, and edibles. The company maintains cultivation and production assets in multiple regulated U.S. markets and historically held operations in Canada.

The company operates across both medical and adult-use cannabis markets, with significant emphasis on U.S. state-level regulatory environments that restrict license availability. TerrAscend controls cultivation facilities, processing infrastructure, and retail licenses in several jurisdictions, enabling operational integration and margin capture across the supply chain. Strategic relationships and acquisitions have played a major role in market expansion, including the acquisition of Gage Growth Corp., which strengthened the company’s position in Michigan. Public filings and investor disclosures also identify partnerships with cannabis genetics, branded product manufacturers, and local operators in regulated state markets.

Strategic Position & Investments

TerrAscend’s strategic direction has centered on expanding its footprint in high-growth, limited-license U.S. cannabis markets while improving operational efficiency and brand penetration. The company has prioritized scaling retail operations, increasing cultivation capacity, and developing premium cannabis brands aimed at both medical and adult-use consumers. Management has consistently emphasized adjusted EBITDA generation, cash flow improvement, and disciplined capital allocation in public filings and investor communications.

Major strategic investments have included acquisitions of dispensary assets, cultivation facilities, and regional operators to strengthen market share. The acquisition of Gage Growth Corp. represented one of the company’s most significant expansion initiatives, substantially increasing its presence in Michigan’s adult-use cannabis market. TerrAscend has also invested in production technologies, indoor cultivation optimization, and brand development initiatives intended to support wholesale growth and retail differentiation. The company’s involvement in emerging cannabis categories includes concentrates, infused products, and premium flower brands, though broader federal legalization opportunities in the United States remain dependent on future regulatory developments.

Geographic Footprint

TerrAscend’s operations are concentrated primarily in the United States, with a historical presence in Canada. The company’s headquarters has been associated with Toronto, Ontario, while operational leadership and commercial activities are heavily focused on U.S. cannabis markets. Its principal U.S. operating regions include Pennsylvania, New Jersey, Maryland, Michigan, and California, where it operates cultivation sites, manufacturing facilities, and retail dispensaries.

The company’s market presence is strongest in states with regulated medical and adult-use cannabis frameworks and limited-license structures. Through vertically integrated operations and retail branding, TerrAscend has established influence across multiple regional cannabis markets in North America. Public disclosures indicate that the company has continued to rationalize and focus its geographic portfolio toward jurisdictions with stronger long-term profitability potential and favorable regulatory conditions.

Leadership & Governance

TerrAscend is governed by a board of directors and executive leadership team with experience in cannabis operations, finance, consumer products, and regulated industries. The company’s leadership strategy has emphasized operational discipline, market-specific execution, and expansion in limited-license jurisdictions. Public communications from management have consistently focused on profitability, retail growth, and maintaining strong positions in strategically important U.S. cannabis markets.

Key executives include:

• Jason Wild – Executive Chairman
• Ziad Ghanem – Chief Executive Officer
• Keith Stauffer – Chief Financial Officer
• Valter Pinto – President
• Stacy Heller – Chief Administrative Officer
• Ryan Hudson – Senior Vice President of Finance

Leadership and governance information has been consistently referenced in company filings, investor presentations, and public market disclosures, including SEC filings and Canadian securities disclosures.